Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States
Tavakkoli, Anna; Singal, Amit G.; Waljee, Akbar K.; Scheiman, James M.; Murphy, Caitlin C.; Pruitt, Sandi L.; Xuan, Lei; Kwon, Richard S.; Law, Ryan J.; Elta, Grace H.; Wright‐slaughter, Phyllis; Valley, Thomas S.; Kubiliun, Nisa; Nathan, Hari; Rubenstein, Joel H.; Elmunzer, B. Joseph
2019-07
View/ Open
Citation
Tavakkoli, Anna; Singal, Amit G.; Waljee, Akbar K.; Scheiman, James M.; Murphy, Caitlin C.; Pruitt, Sandi L.; Xuan, Lei; Kwon, Richard S.; Law, Ryan J.; Elta, Grace H.; Wright‐slaughter, Phyllis ; Valley, Thomas S.; Kubiliun, Nisa; Nathan, Hari; Rubenstein, Joel H.; Elmunzer, B. Joseph (2019). "Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States." Cancer Medicine 8(7): 3420-3427.
Abstract
BackgroundPancreatic cancer is projected to become the second leading cause of cancerâ related deaths by 2030. Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as firstâ line therapy for biliary decompression in pancreatic cancer. The aim of our study was to characterize geographic and racial/ethnic disparities in ERCP utilization among patients with pancreatic cancer.MethodsRetrospective cohort study using the US Surveillance, Epidemiology, and End Results (SEER)â Medicare database to identify patients diagnosed with pancreatic cancer from 2003â 2013. The primary outcome was receipt of ERCP, with or without stent placement, vs any nonâ ERCP biliary intervention.ResultsOf the 36 619 patients with pancreatic cancer, 37.5% (n = 13 719) underwent an ERCP, percutaneous drainage, or surgical biliary bypass. The most common biliary intervention (82.6%) was ERCP. After adjusting for tumor location and stage, Blacks were significantly less likely to receive ERCP than Whites (aOR 0.84, 95% CI 0.72, 0.97) and more likely to receive percutaneous transhepatic biliary drainage (PTBD) (aOR 1.38, 95% CI 1.14, 1.66). Patients in the Southeast and the West were more likely to receive ERCP than those in the Northeast (Southeast aOR 1.21, 95% CI 1.04, 1.40; West aOR 1.16, 95% CI 1.01, 1.32).ConclusionRacial/ethnic and geographic disparities in access to biliary interventions including ERCP exist for patients with pancreatic cancer in the United States. Our results highlight the need for further research and policies to improve access to appropriate biliary intervention for all patients.To date, disparities in the receipt of endoscopic therapies among patients with pancreatic cancer have not been reported. The results from our study suggest that blacks with pancreatic cancer and patients in the Northeast region of the US are less likely to receive the gold standard therapy for obstructive jaundice.Publisher
Wiley Periodicals, Inc.
ISSN
2045-7634 2045-7634
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.